Tue, January 25, 2011
Mon, January 24, 2011
Sun, January 23, 2011
Sat, January 22, 2011
Fri, January 21, 2011
Thu, January 20, 2011
Wed, January 19, 2011
Tue, January 18, 2011
Mon, January 17, 2011
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ] - Market Wire
ICON Acquires Oxford Outcomes
Thu, January 13, 2011
Wed, January 12, 2011
Tue, January 11, 2011
Mon, January 10, 2011
[ Mon, Jan 10th 2011 ] - Market Wire
Teleflex Acquires VasoNova Inc.
[ Mon, Jan 10th 2011 ] - Market Wire
30 A.M. ET
Sun, January 9, 2011
Fri, January 7, 2011
Thu, January 6, 2011
Wed, January 5, 2011
Tue, January 4, 2011
Mon, January 3, 2011
Fri, December 31, 2010
Thu, December 30, 2010
Wed, December 29, 2010
Tue, December 28, 2010
Mon, December 27, 2010
Fri, December 24, 2010
Thu, December 23, 2010
Wed, December 22, 2010
Tue, December 21, 2010
Mon, December 20, 2010

Teva to Present at the 29th Annual J.P. Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2011/ .. 9th-annual-j-p-morgan-healthcare-conference.html
Published in Health and Fitness on Friday, January 7th 2011 at 10:05 GMT by Market Wire   Print publication without navigation


JERUSALEM--([ BUSINESS WIRE ])--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the 29th Annual J.P. Morgan Healthcare Conference with Eyal Desheh, CFO, Teva Pharmaceutical Industries Ltd. and William Marth, President & CEO, Teva Pharmaceuticals - Americas, presenting on Tuesday, January 11, 2011 in San Francisco.

What:

Teva Presentation at the 29th Annual J.P. Morgan Healthcare Conference

Who:

Eyal Desheh, CFO, Teva Pharmaceutical Industries and
William Marth, President & CEO, Teva Pharmaceuticals a" Americas

When:

Tuesday, January 11th, 2011, at 1:30 PM Pacific Standard Time

Where:

[ www.tevapharm.com/financial/ ] or

[ http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink?ticker=TEVA ]

How:

Live over the Internet a" log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will also be available on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva's leading innovative product, Copaxone®, is the number one prescribed treatment for multiple sclerosis. Teva employs more than 40,000 people around the world and reached $13.9 billion in net sales in 2009.


Publication Contributing Sources